Isolating toxic insulin amyloid reactive species that lack B-sheets and have wide pH stability

Biophysical Journal

Volumn 100, Issue 11, 2011, Pages 2792-2800

  Heldt, Caryn L ^a   Kurouski, Dmitry ^b   Sorci, Mirco ^a   Grafeld, Elizabeth ^a   Lednev, Igor K ^b   Belfort, Georges ^a  

^a Rensselaer Polytechnic Institute   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960320827     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2011.04.046     Document Type: Article

References (63)

1. Nielsen, L., R. Khurana, ..., A. L. Fink. 2001. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry. 40:6036-6046. (Pubitemid 32466306)
2. Shankar, G. M., S. M. Li, ..., D. J. Selkoe. 2008. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14:837-842.
3. LaFerla, F. M. 2002. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 3:862-872. (Pubitemid 135706704)
4. Pigino, G., G. Morfini, ..., S. Brady. 2009. Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc. Natl. Acad. Sci. USA. 106:5907-5912.
5. Friedrich, R. P., K. Tepper, ..., M. Fändrich. 2010. Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proc. Natl. Acad. Sci. USA. 107:1942-1947.
6. Quist, A., I. Doudevski, ..., R. Lal. 2005. Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. USA. 102:10427-10432. (Pubitemid 41061570)
7. Nayak, A., M. Sorci, ..., G. Belfort. 2009. A universal pathway for amyloid nucleus and precursor formation for insulin. Proteins. 74:556-565.
8. Vestergaard, B., M. Groenning, ..., D. I. Svergun. 2007. A helical structural nucleus is the primary elongating unit of insulin amyloid fibrils. PLoS Biol. 5:e134.
9. Meng, G., N. Arkus, ..., V. N. Manoharan. 2010. The free-energy landscape of clusters of attractive hard spheres. Science. 327:560-563.
10. Pease III, L. F., M. Sorci, ..., G. Belfort. 2010. Probing the nucleus model for oligomer formation during insulin amyloid fibrillogenesis. Biophys. J. 99:3979-3985.
11. Schmit, J. D., K. Ghosh, and K. Dill. 2011. What drives amyloid molecules to assemble into oligomers and fibrils? Biophys. J. 100:450-458.
12. Ladiwala, A. R. A., J. C. Lin, ..., P. M. Tessier. 2010. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into off-pathway conformers. J. Biol. Chem. 285:24228-24237.
13. Stine Jr., W. B., K. N. Dahlgren, ..., M. J. LaDu. 2003. In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol. Chem. 278:11612-11622. (Pubitemid 36792723)
14. Sandberg, A., L. M. Luheshi, ..., T.Härd. 2010. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering. Proc. Natl. Acad. Sci. USA. 107:15595-15600.
15. Kayed, R., E. Head, ..., C. G. Glabe. 2003. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 300:486-489. (Pubitemid 36444329)
16. Campioni, S., B. Mannini, ..., F. Chiti. 2010. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat. Chem. Biol. 6:140-147.
17. Bolognesi, B., J. R. Kumita, ..., J. J. Yerbury. 2010. ANS binding reveals common features of cytotoxic amyloid species. ACS Chem. Biol. 5:735-740.
18. Tiwari, A., A. Liba, ..., L. J. Hayward. 2009. Metal deficiency increases aberrant hydrophobicity of mutant superoxide dismutases that cause amyotrophic lateral sclerosis. J. Biol. Chem. 284:27746- 27758.
19. Romero, D., C. Aguilar, ..., R. Kolter. 2010. Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proc. Natl. Acad. Sci. USA. 107:2230-2234.
20. Smith, J. F., T. P. J. Knowles, ..., M. E.Welland. 2006. Characterization of the nanoscale properties of individual amyloid fibrils. Proc. Natl. Acad. Sci. USA. 103:15806-15811. (Pubitemid 44657548)
21. Carulla, N., G. L. Caddy, ..., C. M. Dobson. 2005. Molecular recycling within amyloid fibrils. Nature. 436:554-558. (Pubitemid 41112928)
22. Chatani, E., Y.-H. Lee, ..., Y. Goto. 2009. Ultrasonication-dependent production and breakdown lead to minimum-sized amyloid fibrils. Proc. Natl. Acad. Sci. USA. 106:11119-11124.
23. Vernaglia, B. A., J. Huang, and E. D. Clark. 2004. Guanidine hydrochloride can induce amyloid fibril formation from hen egg-white lysozyme. Biomacromolecules. 5:1362-1370. (Pubitemid 39089737)
24. Hirota-Nakaoka, N., K. Hasegawa, ..., Y. Goto. 2003. Dissolution of beta2-microglobulin amyloid fibrils by dimethylsulfoxide. J. Biochem. 134:159-164. (Pubitemid 37071192)
25. Byrne, N., and C. A. Angell. 2009. Formation and dissolution of hen egg white lysozyme amyloid fibrils in protic ionic liquids. Chem. Commun. (Camb.). 9:1046-1048.
26. Malisauskas, M., C. Weise, ..., L. Morozova-Roche. 2010. Lability landscape and protease resistance of human insulin amyloid: a new insight into its molecular properties. J. Mol. Biol. 396:60-74.
27. Knowles, T. P. J., C. A.Waudby, ..., C. M. Dobson. 2009. An analytical solution to the kinetics of breakable filament assembly. Science. 326:1533-1537.
28. Dische, F. E., C. Wernstedt, ..., P. J. Watkins. 1988. Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia. 31:158-161.
29. Ivanova, M. I., S. A. Sievers, ..., D. Eisenberg. 2009. Molecular basis for insulin fibril assembly. Proc. Natl. Acad. Sci. USA. 106:18990- 18995.
30. Heldt, C. L., M. Sorci, ..., G. Belfort. 2011. Detection and reduction of microaggregates in insulin preparations. Biotechnol. Bioeng. 108:237-241.
31. Sorci, M., R. A. Grassucci, ..., G. Belfort. 2009. Time-dependent insulin oligomer reaction pathway prior to fibril formation: cooling and seeding. Proteins. 77:62-73.
32. Heldt, C. L., S. Zhang, and G. Belfort. 2011. Asymmetric amyloid fibril elongation: a new perspective on a symmetric world. Proteins. 79:92-98.
33. Whitmore, L., and B. A. Wallace. 2008. Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers. 89:392-400.
34. Compton, L. A., and W. C. J. Johnson Jr. 1986. Analysis of protein circular dichroism spectra for secondary structure using a simple matrix multiplication. Anal. Biochem. 155:155-167. (Pubitemid 16034476)
35. Janes, R. W. 2008. Reference datasets circular dichroism and synchrotron radiation circular dichroism spectroscopy of proteins. In Modern Techniques in Circular Dichroism and Synchrotron Radiation Circular Dichroism Spectroscopy. B. A. Wallace and R. W. Janes, editors. IOS Press, Amsterdam, The Netherlands. 183-201.
36. Lednev, I. K., V. V. Ermolenkov, ..., M. Xu. 2005. Deep-UV Raman spectrometer tunable between 193 and 205 nm for structural characterization of proteins. Anal. Bioanal. Chem. 381:431-437. (Pubitemid 40249165)
37. Heldt, C. L., R. Hernandez, ..., R. G. Carbonell. 2006. A colorimetric assay for viral agents that produce cytopathic effects. J. Virol. Methods. 135:56-65. (Pubitemid 43728850)
38. Guinier, A., and G. Fournet. 1955. Small-Angle Scattering of X-Rays. Wiley, New York.
39. Haas, J., E. Vöhringer-Martinez, ..., H. Grubmüller. 2009. Primary steps of pH-dependent insulin aggregation kinetics are governed by conformational flexibility. ChemBioChem. 10:1816-1822.
40. Sethuraman, A., M. Han, ..., G. Belfort. 2004. Effect of surface wettability on the adhesion of proteins. Langmuir. 20:7779-7788.
41. Pocker, Y., and S. B. Biswas. 1980. Conformational dynamics of insulin in solution. Circular dichroic studies. Biochemistry. 19:5043-5049. (Pubitemid 11205883)
42. Tiyaboonchai, W., J. Woiszwillo, ..., C. R. Middaugh. 2003. Insulin containing polyethylenimine-dextran sulfate nanoparticles. Int. J. Pharm. 255:139-151. (Pubitemid 36369598)
43. Hua, Q.-X., W. Jia, ..., M. A.Weiss. 2002. A protein caught in a kinetic trap: structures and stabilities of insulin disulfide isomers. Biochemistry. 41:14700-14715. (Pubitemid 35470650)
44. Lednev, I. K. 2007. Vibrational spectroscopy: biological applications of ultraviolet Raman spectroscopy. In Protein Structures, Methods in Protein Structures and Stability Analysis. V. N. Uversky and E. A. Permyakov, editors. Nova Science Publishers, New York. 1-26.
45. Shashilov, V. A., V. Sikirzhytski, ..., I. K. Lednev. 2010. Quantitative methods for structural characterization of proteins based on deep UV resonance Raman spectroscopy. Methods. 52:23-37.
46. Podestà, A., G. Tiana, ..., M. Manno. 2006. Early events in insulin fibrillization studied by time-lapse atomic force microscopy. Biophys. J. 90:589-597.
47. Bouchard, M., J. Zurdo, ..., C. V. Robinson. 2000. Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopy. Protein Sci. 9:1960-1967.
48. Krebs, M. R. H., E. H. C. Bromley, ..., A. M. Donald. 2005. The mechanism of amyloid spherulite formation by bovine insulin. Biophys. J. 88:2013-2021. (Pubitemid 40976211)
49. Novitskaya, V., O. V. Bocharova, ..., I. V. Baskakov. 2006. Amyloid fibrils of mammalian prion protein are highly toxic to cultured cells and primary neurons. J. Biol. Chem. 281:13828-13836. (Pubitemid 43855298)
50. Vilasi, S., C. Iannuzzi, ..., I. Sirangelo. 2008. Effect of trehalose on W7FW14F apomyoglobin and insulin fibrillization: new insight into inhibition activity. Biochemistry. 47:1789-1796. (Pubitemid 351231228)
51. Liu, Y. B., and D. Schubert. 1998. Steroid hormones block amyloid fibril-induced 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) formazan exocytosis: relationship to neurotoxicity. J. Neurochem. 71:2322-2329. (Pubitemid 28531242)
52. Maji, S. K., M. H. Perrin, ..., R. Riek. 2009. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science. 325:328-332.
53. Datki, Z., A. Juhász, ..., B. Penke. 2003. Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells. Brain Res. Bull. 62:223-229. (Pubitemid 38091710)
54. Lee, S., E. J. Fernandez, and T. A. Good. 2007. Role of aggregation conditions in structure, stability, and toxicity of intermediates in the Abeta fibril formation pathway. Protein Sci. 16:723-732. (Pubitemid 46507001)
55. Xu, M., V. V. Ermolenkov, ..., I. K. Lednev. 2008. Hen egg white lysozyme fibrillation: a deep-UV resonance Raman spectroscopic study. J Biophotonics. 1:215-229.
56. Sikirzhytski, V., N. I. Topilina, ..., I. K. Lednev. 2008. Genetic engineering combined with deep UV resonance Raman spectroscopy for structural characterization of amyloid-like fibrils. J. Am. Chem. Soc. 130:5852-5853. (Pubitemid 351620819)
57. Martins, I. C., I. Kuperstein, ..., F. Rousseau. 2008. Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J. 27:224-233.
58. Tjernberg, A., N. Markova, ..., D. Hallén. 2006. DMSO-related effects in protein characterization. J. Biomol. Screen. 11:131-137.
59. Monera, O. D., C. M. Kay, and R. S. Hodges. 1994. Protein denaturation with guanidine hydrochloride or urea provides a different estimate of stability depending on the contributions of electrostatic interactions. Protein Sci. 3:1984-1991.
60. Topilina, N. I., V. Sikirzhytsky, ..., J. T. Welch. 2010. Charge distribution and amyloid fibril formation: insights from genetically engineered model systems. Biomacromolecules. 11:1721-1726.
61. Yu, L., R. Edalji, ..., E. T. Olejniczak. 2009. Structural characterization of a soluble amyloid beta-peptide oligomer. Biochemistry. 48:1870- 1877.
62. Paravastu, A. K., I. Qahwash, ..., R. Tycko. 2009. Seeded growth of beta-amyloid fibrils from Alzheimer's brain-derived fibrils produces a distinct fibril structure. Proc. Natl. Acad. Sci. USA. 106:7443-7448.
63. Glabe, C. G. 2008. Structural classification of toxic amyloid oligomers. J. Biol. Chem. 283:29639-29643.